Issue Open Date
|
14-Jul-25
|
Issue Closing Date
|
16-Jul-25
|
Application Money
|
100
|
Allotment Money
|
|
|
Price Band
|
540
-
570
|
Minimium Application No.
|
26
|
Issue Size (Shares)
|
62885959
|
Market Lot
|
1
|
|
|
Objective
|
(i) to carry out the Offer for Sale of up to [?] Equity Shares of face value of ? 2 each by theSelling Shareholders aggregating up to ? 33,950.00 million; and(ii) achieve the benefits of listing the Equity Shares on the Stock Exchanges.
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
Offered / Reserved |
Bid For |
|
Non-Institutional Investors
|
|
|
|
Qualified Institutional Buyers
|
|
|
|
Retail Individual Investors
|
|
|
|
|
|
|
Business Description
We are an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization(“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing. We are one ofthe few companies in India wi
|
|
Promoter's Holding
|
Total Share Capital
|
431747949
|
Offered to Public
|
62885959
|
Promoter's Holding (Pre-Issue)
|
77.23
|
Promoter's Holding (Post-Issue)
|
|
|
MORE > |
|
|
|
|
|
Address |
No. 49 F1 & F2 Canara Bank Road Bommasandra Industrial Area Phase I Bommasandra
Bengaluru
,
Karnataka
,
560099
Phone :
080-66724000
Email :
investors.abl@anthembio.com
Website :
www.anthembio.com
|
|
Registrar |
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B Plot 31-32 Gachibowli Financial District Nanakramguda Hyderabad
|
|
Listed at |
BSE, NSE
|
|
Lead Manager |
Citigroup Global Markets India Pvt Ltd. JM Financial Ltd. JP Morgan India Pvt Ltd Nomura Financial Advisory & Securities (India) Pvt Ltd.
|
|
Promoters |
Ajay Bhardwaj Ganesh Sambasivam Ishaan Bhardwaj K Ravindra Chandrappa
|
|